InnoCare Pharma Limited (HKG: 9969)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
6.71
-0.11 (-1.61%)
Oct 9, 2024, 4:08 PM HKT

InnoCare Pharma Revenue

InnoCare Pharma had revenue of 253.91M CNY in the quarter ending June 30, 2024, with 34.94% growth. This brings the company's revenue in the last twelve months to 780.73M, up 3.13% year-over-year. In the year 2023, InnoCare Pharma had annual revenue of 738.54M with 18.09% growth.

Revenue (ttm)
780.73M CNY
Revenue Growth
+3.13%
P/S Ratio
13.82
Revenue / Employee
716.92K CNY
Employees
1,089
Market Cap
14.21B HKD

Revenue Chart

* This company reports financials in CNY.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023738.54M113.13M18.09%
Dec 31, 2022625.40M-417.63M-40.04%
Dec 31, 20211.04B1.04B76,368.70%
Dec 31, 20201.36M117.00K9.38%
Dec 31, 20191.25M-370.00K-22.88%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition